These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 25321330)
21. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study. Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062 [TBL] [Abstract][Full Text] [Related]
22. Post-transplant Burkitt lymphoma is a more aggressive and distinct form of post-transplant lymphoproliferative disorder. Picarsic J; Jaffe R; Mazariegos G; Webber SA; Ellis D; Green MD; Reyes-Múgica M Cancer; 2011 Oct; 117(19):4540-50. PubMed ID: 21446044 [TBL] [Abstract][Full Text] [Related]
23. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
24. Infection with Epstein-Barr virus and cancer: an epidemiological review. Serraino D; Piselli P; Angeletti Cl; Scuderi M; Ippolito G; Capobianchi MR J Biol Regul Homeost Agents; 2005; 19(1-2):63-70. PubMed ID: 16178276 [TBL] [Abstract][Full Text] [Related]
26. EBV-positive extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in the posttransplant setting: a distinct type of posttransplant lymphoproliferative disorder? Gibson SE; Swerdlow SH; Craig FE; Surti U; Cook JR; Nalesnik MA; Lowe C; Wood KM; Bacon CM Am J Surg Pathol; 2011 Jun; 35(6):807-15. PubMed ID: 21552113 [TBL] [Abstract][Full Text] [Related]
27. Clinicopathologic comparison of plasmablastic lymphoma in HIV-positive, immunocompetent, and posttransplant patients: single-center series of 25 cases and meta-analysis of 277 reported cases. Morscio J; Dierickx D; Nijs J; Verhoef G; Bittoun E; Vanoeteren X; Wlodarska I; Sagaert X; Tousseyn T Am J Surg Pathol; 2014 Jul; 38(7):875-86. PubMed ID: 24832164 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis. Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979 [TBL] [Abstract][Full Text] [Related]
29. Epstein-Barr virus-infected cells in IgG4-related lymphadenopathy with comparison with extranodal IgG4-related disease. Takeuchi M; Sato Y; Yasui H; Ozawa H; Ohno K; Takata K; Gion Y; Orita Y; Tachibana T; Itoh T; Asano N; Nakamura S; Swerdlow SH; Yoshino T Am J Surg Pathol; 2014 Jul; 38(7):946-55. PubMed ID: 24705309 [TBL] [Abstract][Full Text] [Related]
30. Plasma EBV-DNA monitoring in Epstein-Barr virus-positive Hodgkin lymphoma patients. Spacek M; Hubacek P; Markova J; Zajac M; Vernerova Z; Kamaradova K; Stuchly J; Kozak T APMIS; 2011 Jan; 119(1):10-6. PubMed ID: 21143522 [TBL] [Abstract][Full Text] [Related]
31. Prognostic Impact of MUM1/IRF4 Expression in Burkitt Lymphoma (BL): A Reappraisal of 88 BL Patients in Japan. Satou A; Asano N; Kato S; Elsayed AA; Nakamura N; Miyoshi H; Ohshima K; Nakamura S Am J Surg Pathol; 2017 Mar; 41(3):389-395. PubMed ID: 28079574 [TBL] [Abstract][Full Text] [Related]
32. Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features. Chuang SS; Huang WT; Hsieh PP; Jung YC; Ye H; Du MQ; Lu CL; Cho CY; Hsiao SC; Hsu YH; Lin KJ Histopathology; 2008 Mar; 52(4):427-35. PubMed ID: 18315595 [TBL] [Abstract][Full Text] [Related]
33. Epstein-Barr virus infection and altered control of apoptotic pathways in posttransplant lymphoproliferative disorders. Ghigna MR; Reineke T; Rincé P; Schüffler P; El Mchichi B; Fabre M; Jacquemin E; Durrbach A; Samuel D; Joab I; Guettier C; Lucioni M; Paulli M; Tinguely M; Raphael M Pathobiology; 2013; 80(2):53-9. PubMed ID: 22868923 [TBL] [Abstract][Full Text] [Related]
34. EBV-associated Burkitt lymphoma in Taiwan is not age-related. Chen BJ; Chang ST; Weng SF; Huang WT; Chu PY; Hsieh PP; Jung YC; Kuo CC; Chuang YT; Chuang SS Leuk Lymphoma; 2016; 57(3):644-53. PubMed ID: 26422188 [TBL] [Abstract][Full Text] [Related]
35. From Burkitt's lymphoma to chronic active Epstein-Barr virus (EBV) infection: an expanding spectrum of EBV-associated diseases. Okano M; Gross TG Pediatr Hematol Oncol; 2001; 18(7):427-42. PubMed ID: 11594706 [TBL] [Abstract][Full Text] [Related]
36. Burkitt lymphoma in Brazil is characterized by geographically distinct clinicopathologic features. Queiroga EM; Gualco G; Weiss LM; Dittmer DP; Araujo I; Klumb CE; Harrington WJ; Bacchi CE Am J Clin Pathol; 2008 Dec; 130(6):946-56. PubMed ID: 19019773 [TBL] [Abstract][Full Text] [Related]
37. Latent Epstein-Barr virus infection of tumor cells in classical Hodgkin's lymphoma predicts adverse outcome in older adult patients. Diepstra A; van Imhoff GW; Schaapveld M; Karim-Kos H; van den Berg A; Vellenga E; Poppema S J Clin Oncol; 2009 Aug; 27(23):3815-21. PubMed ID: 19470931 [TBL] [Abstract][Full Text] [Related]
38. TCL1 expression and Epstein-Barr virus status in pediatric Burkitt lymphoma. Teitell MA; Lones MA; Perkins SL; Sanger WG; Cairo MS; Said JW Am J Clin Pathol; 2005 Oct; 124(4):569-75. PubMed ID: 16146820 [TBL] [Abstract][Full Text] [Related]
39. Impact of Epstein-Barr virus in the clinical evolution of patients with classical Hodgkin's lymphoma in Brazil. Souza EM; Baiocchi OC; Zanichelli MA; Alves AC; Assis MG; Eiras DP; Dobo C; Oliveira JS Hematol Oncol; 2010 Sep; 28(3):137-41. PubMed ID: 20128016 [TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-positive nodal peripheral T cell lymphomas: clinicopathologic and gene expression profiling study. Ha SY; Sung J; Ju H; Karube K; Kim SJ; Kim WS; Seto M; Ko YH Pathol Res Pract; 2013 Jul; 209(7):448-54. PubMed ID: 23735590 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]